Researchers have identified a molecular target that could extend the [...]

BullFrog AI Holdings has entered a commercial agreement with a [...]

FundaMental Pharma GmbH will present new preclinical data on its [...]

A genetically targeted approach to depression treatment has shown promising [...]

Clinically validated digital therapeutic launches with UKCA mark and NHS [...]

Cybin’s lead psychedelic-based candidate CYB003, designed as an adjunctive treatment [...]

As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]